Agenus issues Series A, Series B warrants in USD 85 million private placement
AGEN•Private placement terms
Agenus priced a private placement issuing 23,035,227 common shares or pre-funded warrants exercisable at USD 0.01 per share.
The deal includes Series A warrants for 21,144,277 shares at USD 4.02, with up to USD 255 million from full warrant exercise.
Series B warrants and registration rights
Series B warrants cover 33,797,214 shares at USD 5.03, with expiry tied to ROBBIN dosing and pathologic response disclosures.
A registration rights agreement requires resale registration for the shares, pre-funded warrants, Series A warrants, Series B warrants, and underlying shares.
